STAT3 and colorectal carcinoma: Persistent JAK/STAT activation might also be vital for EGFR-targeted resistance, although the increased level of STAT3 phosphorylation seen in in vivo and in vitro studies was related to gefitinib resistance, which could be overcome by silencing STAT3 in CRC cells.152,153